SCHEMBL21887915

SCHEMBL21887915

CC1(C)c2ccccc2-c2ccc(C3(c4ccccc4)c4ccccc4Nc4ccccc43)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
MAPT P10636 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
OPRK1 P41145 1/20 0.40
XBP1 P17861 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CHRM2 P08172 2/20 0.38
KCNH2 Q12809 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37
POLB P06746 1/20 0.33
PGR P06401 1/20 0.31
HTR5A P47898 2/20 0.31
KIF11 P52732 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21887930 0.91 LMNA (0.45) LMNAESR1ESR2MAPTMEN1
SCHEMBL31757120 0.88 ESR1 (0.44) LMNAESR1ESR2MAPTMEN1
SCHEMBL31757119 0.88 ESR1 (0.46) LMNAESR1ESR2MAPTMEN1
SCHEMBL19764683 0.81 ESR1 (0.40) LMNAESR1ESR2MAPTMEN1
SCHEMBL19764661 0.81 ESR1 (0.40) LMNAESR1ESR2MAPTMEN1
SCHEMBL21887912 0.81 POLB (0.44) LMNAESR1ESR2MAPTMEN1
SCHEMBL24328671 0.80 ESR1 (0.42) LMNAESR1ESR2MAPTMEN1
SCHEMBL23335626 0.78 LMNA (0.41) LMNAESR1ESR2MAPTMEN1
SCHEMBL25937157 0.78 LMNA (0.52) LMNAESR1ESR2MAPTMEN1
SCHEMBL21585374 0.77 PDK2 (0.40) LMNAESR1ESR2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020056859-A1 9,10-DIHYDROACRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 宁波卢米蓝新材料有限公司 2020-03-26 WO disclosed
US-20200091436-A1 9,10-DIHYDRO-ACRIDINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200091436-A1 9,10-DIHYDRO-ACRIDINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF DHODH, DHRS9, QDPR LMNA 1105/4885ESR1 433/4885ESR2 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.